EP Patent

EP0415566A1 — Heterocyclic compounds, processes for producing them and pharmaceutical compositions comprising them

Assigned to Shionogi and Co Ltd · Expires 1991-03-06 · 35y expired

What this patent protects

Novel heterocyclic compounds capable of lowenng the und acid levels in plasma and unne having the formula (I) wherein R 2 and R 2 are independently hydrogen, lower alkyl, phenyl or substituted phenyl, or R' and R 2 may form a four to eight-membered carbon ring together wi…

USPTO Abstract

Novel heterocyclic compounds capable of lowenng the und acid levels in plasma and unne having the formula (I) wherein R 2 and R 2 are independently hydrogen, lower alkyl, phenyl or substituted phenyl, or R' and R 2 may form a four to eight-membered carbon ring together with the carbon atom to which they are attached: R 3 is hydrogen or lower alkyl: R 4 is one or two radicals selected from a group consisting of hydrogen, halogen, nitro. lower alkyl. phenyl. substituted phenyl, -OR 5 and -SO 2 NR 6 R 6 ; R 5 is hydrogen. lower alkyl phenyl-substituted lower alkyl. carboxymethyl or ester thereof, hydroxethyl or ether thereof, or allyl; R 6 and R 6 are independently hydrogen or lower alkyl: R 7 is hydrogen or a pharmaceutically active ester-forming group: A is a straight or branched hydrocarbon radical having one to five carbon atoms: B is halogen. oxygen, or dithiolane; Y is oxygen. sulfur, nitrogen or substituted nitrogen; Z is oxygen, nitrogen or substituted nitrogen: dotted line represents the presence or absence of a single bond, processes for their production and pharmaceutical compositions comprising them.

Drugs covered by this patent

Patent Metadata

Patent number
EP0415566A1
Jurisdiction
EP
Classification
Expires
1991-03-06
Drug substance claim
No
Drug product claim
No
Assignee
Shionogi and Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.